Stanley G. Rockson, M.D.
From Stanford University School of Medicine, Stanford, CA. Address reprint requests to Dr. Rockson at the Falk Cardiovascular Research Center, Stanford University School of Medicine, 300 Pasteur Dr., Stanford, CA 94305, or at email@example.com.
1. Dylke ES, Schembri GP, Bailey DL, et al. Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol 2016;55:1477-1483.
2. Rockson SG. Precipitating factors in lymphedema: myths and realities. Cancer 1998;83:12 Suppl American:2814-2816.
3. McLaughlin SA, Staley AC, Vicini F, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS panel — Part 1: definitions, assessments, education, and future directions. Ann Surg Oncol 2017;24:2818-2826.
4. Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 2010;116:5138-5149.
5. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci 2008;1131:147-154.
6. Wernicke AG, Goodman RL, Turner BC, et al. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat 2011;125:893-902.
7. Hayes S, Cornish B, Newman B. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 2005;89:221-226.
8. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013;14:500-515.
9. McLaughlin SA, DeSnyder SM, Klimberg S, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from an expert panel — Part 2: preventive and therapeutic options. Ann Surg Oncol 2017;24:2827-2835.
10. Iyigun ZE, Duymaz T, Ilgun AS, et al. Preoperative lymphedema-related risk factors in early-stage breast cancer. Lymphat Res Biol 2018;16:28-35.
11. Vieira RA, da Costa AM, de Souza JL, et al. Risk factors for arm lymphedema in a cohort of breast cancer patients followed up for 10 years. Breast Care (Basel) 2016;11:45-50.
12. Wetzig N, Gill PG, Espinoza D, et al. Sentinel-lymph-node-based management or routine axillary clearance? Five-year outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 trial: assessment and incidence of true lymphedema. Ann Surg Oncol 2017;24:1064-1070.
13. Brorson H, Ohlin K, Olsson G, Karlsson MK. Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue. Lymphat Res Biol 2009;7:3-10.
14. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2009 consensus document of the International Society of Lymphology. Lymphology 2009;42:51-60.
15. Boughey JC, Hoskin TL, Cheville AL, et al. Risk factors associated with breast lymphedema. Ann Surg Oncol 2014;21:1202-1208.
16. Szolnoky G. Differential diagnosis: lipedema. In: Lee BB, Rockson SG, Bergan J, eds. Lymphedema: a concise compendium of theory and practice. 2nd ed. London: Springer, 2018:239-49.
17. Szuba A, Razavi M, Rockson SG. Diagnosis and treatment of concomitant venous obstruction in patients with secondary lymphedema. J Vasc Interv Radiol 2002;13:799-803.
18. Bae JS, Yoo RE, Choi SH, et al. Evaluation of lymphedema in upper extremities by MR lymphangiography: comparison with lymphoscintigraphy. Magn Reson Imaging 2018;49:63-70.
19. Mihara M, Hara H, Araki J, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs. PLoS One 2012;7(6):e38182-e38182.
20. Stout NL, Pfalzer LA, Springer B, et al. Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther 2012;92:152-163.
21. Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol 2014;12:289-294.
22. Czerniec SA, Ward LC, Kilbreath SL. Assessment of breast cancer-related lymphedema: a comparison of moisture meter and spot bioimpedance measurement. Lymphat Res Biol 2015;13:10-19.
23. Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis. J Plast Reconstr Aesthet Surg 2018;71:1041-1050.
24. Ferguson CM, Swaroop MN, Horick N, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol 2016;34:691-698.
25. Basta MN, Fox JP, Kanchwala SK, et al. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg 2016;211:133-141.
26. Boyages J, Kalfa S, Xu Y, et al. Worse and worse off: the impact of lymphedema on work and career after breast cancer. Springerplus 2016;5:657-657.
27. Moffatt CJ, Doherty DC, Franks PJ, Mortimer PS. Community-based treatment for chronic edema: an effective service model. Lymphat Res Biol 2018;16:92-99.
28. Huang TW, Tseng SH, Lin CC, et al. Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. World J Surg Oncol 2013;11:15-15.
29. Ezzo J, Manheimer E, McNeely ML, et al. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev 2015;5:CD003475-CD003475.
30. Rockson SG. Current concepts and future directions in the diagnosis and management of lymphatic vascular disease. Vasc Med 2010;15:223-231.
31. Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH. The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema. JAMA Dermatol 2015;151:1187-1193.
32. Shao Y, Qi K, Zhou QH, Zhong DS. Intermittent pneumatic compression pump for breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. Oncol Res Treat 2014;37:170-174.
33. Schmitz KH, Ahmed RL, Troxel A, et al. Weight lifting in women with breast-cancer–related lymphedema. N Engl J Med 2009;361:664-673.
34. Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 2010;304:2699-2705.
35. Kilbreath SL, Refshauge KM, Beith JM, et al. Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial. Breast Cancer Res Treat 2012;133:667-676.
36. Hayes SC, Reul-Hirche H, Turner J. Exercise and secondary lymphedema: safety, potential benefits, and research issues. Med Sci Sports Exerc 2009;41:483-489.
37. Cornelissen AJM, Beugels J, Ewalds L, et al. The effect of lymphaticovenous anastomosis in breast cancer-related lymphedema: a review of the literature. Lymphat Res Biol 2018 January 22 (Epub ahead of print).
38. Pappalardo M, Patel K, Cheng MH. Vascularized lymph node transfer for treatment of extremity lymphedema: an overview of current controversies regarding donor sites, recipient sites and outcomes. J Surg Oncol 2018;117:1420-1431.
39. Boccardo F, Casabona F, De Cian F, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery 2014;34:421-424.
40. Ozmen T, Lazaro M, Zhou Y, Vinyard A, Avisar E. Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (S-LYMPHA) for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection. Ann Surg 2018 May 23 (Epub ahead of print).
41. Brorson H. Liposuction in lymphedema treatment. J Reconstr Microsurg 2016;32:56-65.
42. Lee D, Piller N, Hoffner M, Manjer J, Brorson H. Liposuction of postmastectomy arm lymphedema decreases the incidence of erysipelas. Lymphology 2016;49:85-92.
43. Schaverien MV, Munnoch DA, Brorson H. Liposuction treatment of lymphedema. Semin Plast Surg 2018;32:42-47.
44. Kilbreath SL, Lee MJ, Refshauge KM, et al. Transient swelling versus lymphoedema in the first year following surgery for breast cancer. Support Care Cancer 2013;21:2207-2215.
45. Specht MC, Miller CL, Russell TA, et al. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat 2013;140:485-494.
46. Laidley A, Anglin B. The impact of L-Dex(®) measurements in assessing breast cancer-related lymphedema as part of routine clinical practice. Front Oncol 2016;6:192-192.
47. Parks RM, Cheung KL. Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy — a systematic review of the literature and necessity of a randomised study. Breast 2017;33:57-70.
48. Scaglioni MF, Fontein DBY, Arvanitakis M, Giovanoli P. Systematic review of lymphovenous anastomosis (LVA) for the treatment of lymphedema. Microsurgery 2017;37:947-953.
49. National Comprehensive Cancer Network Breast cancer. 2018 (https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf).